Back

Sep 24, 2023

Change - Announcement Of Appointment Of Non-Executive And Independent Director

Announcement Title Change - Announcement of Appointment
Date & Time of Broadcast Sep 24, 2023 23:42
Status New
Announcement Sub Title Appointment of Non-Executive and Independent Director
Announcement Reference SG230924OTHRJO4P
Submitted By (Co./ Ind. Name) Catherine Yeo
Designation Company Secretary
Description (Please provide a detailed description of the event in the box below) Appointment of Non-Executive and Independent Director and a member of the Audit, Risk and Compliance Committee ("ARCC") and the Nominating and Remuneration Committee ("NRC") of Frasers Centrepoint Asset Management Ltd. ("FCAM"), the manager of Frasers Centrepoint Trust.
Additional Details
Date Of Appointment 26/09/2023
Name Of Person Mr Tan Siew Peng (Darren)
Age 52
Country Of Principal Residence Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process) Mr Tan is currently the Chief Investment Officer of Raffles Medical Group Ltd. He has over 28 years of experience in financial matters.

After having considered the qualifications, expertise and experience of Mr Tan, and with the recommendation of the NRC, the Board approved the appointment of Mr Tan as a Non-Executive and Independent Director of FCAM as well as a member of the ARCC and NRC.

The Board is of the view that the appointment of Mr Tan as a Director of FCAM will provide further diversity to the core competencies and skill set of the Board. The Board considers Mr Tan to be independent for the purposes of Rule 704(8) of the Listing Manual of the Singapore Exchange Securities Trading Limited.
Whether appointment is executive, and if so, the area of responsibility Non-Executive
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Non-Executive and Independent Director and a member of the ARCC and the NRC
Professional qualifications - Stanford Executive Program, Stanford Business School, Stanford University, Palo Alto, California, USA
- Chartered Financial Analyst, Association of Investment Management and Research
- Bachelor of Accountancy (1st Class Honours), Nanyang Technological University - Accountancy
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries Nil
Conflict of interests (including any competing business) Nil
Working experience and occupation(s) during the past 10 years - Chief Investment Officer of Raffles Medical Group Ltd. from 1 March 2023 to present
- Chief Financial Officer of Oversea-Chinese Banking Corporation Limited from March 2011 to December 2022
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6)) Yes
Shareholding interest in the listed issuer and its subsidiaries? No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years) 1. Chief Financial Officer, Oversea-Chinese Banking Corporation Limited
2. Council Member and Chairman of Investment Committee, Institute of Singapore Chartered Accountants
3. Member, Alumni Advisory Board, Nanyang Technological University, Nanyang Business School
4. Adjunct Professor, Nanyang Technological University, Nanyang Business School
5. Director, OCBC Property Services Private Limited
6. Director, OCBC Overseas Investments Pte Ltd
7. Director, OCBC Wing Hang Bank (China) Limited
8. Director, OCBC Bank (Malaysia) Berhad
9. Director, Bank of Ningbo Co., Ltd.
10. Director, Lion Global Investors Limited
11. Director, MaxWealth Asset Management Limited
Present 1. Chief Investment Officer, Raffles Medical Group Ltd.
2. Director, Inland Revenue Authority of Singapore, Tax Academy of Singapore
3. Director, Singapore Management University, School of Accountancy Advisory Board
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? No
(c) Whether there is any unsatisfied judgment against him? No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? No
Any prior experience as a director of an issuer listed on the Exchange? No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange Mr Tan Siew Peng (Darren) will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange.

Get in touch with our IR representative

Contact us